FIELD: biotechnologies.
SUBSTANCE: invention proposes cell line huFSHIK - producer of recombinant human follicle-stimulating hormone (FSH) released to culture liquid. The line releases FSH in suspension culture in concentration of 18IU/106 cells a day.
EFFECT: invention optimises FSH expression system, which leads to increase of its products and improvement of efficiency and cost effectiveness of FSH production for medical purpose.
4 dwg, 7 ex
Authors
Dates
2013-12-27—Published
2012-02-22—Filed